Nakayama K, Abe R
Second Department of Surgery, Fukushima Medical College, Japan.
J Surg Oncol. 1995 Nov;60(3):160-7. doi: 10.1002/jso.2930600305.
Whether argyrophilic nucleolar organizer region (AgNOR) is a predictor of prognosis in breast cancer is controversial. The semiquantitative procedure used to calculate interphasic argyrophilic dots optically is neither reliable nor reproducible. We measured the mean area of AgNOR dots, the mean AgNOR area per nucleus (MA), and the mean AgNOR number per nucleus (MN) by automated image analysis in specimens from 131 patients with breast cancer. Higher MA (> 7.41 microns2), detected in 22 (16.8%) of 131 patients, did not correlate with clinicobiologic variables, except for DNA ploidy status. Overall survival was significantly better in patients with lower MA than in those with higher MA. On multivariate analysis, MA was a significant independent factor, followed by nodal status. These findings indicate that expression of AgNOR should be evaluated in terms of area occupied and that the mean area of AgNOR per nucleus (MA) is an important prognostic factor in the overall survival of breast cancer patients.
嗜银核仁组织区(AgNOR)是否为乳腺癌预后的预测指标仍存在争议。用于光学计算间期嗜银点的半定量方法既不可靠也不可重复。我们通过自动图像分析测量了131例乳腺癌患者标本中AgNOR点的平均面积、每个细胞核的平均AgNOR面积(MA)和每个细胞核的平均AgNOR数量(MN)。在131例患者中有22例(16.8%)检测到较高的MA(>7.41平方微米),除了DNA倍体状态外,其与临床生物学变量无相关性。MA较低的患者总生存期明显优于MA较高的患者。多因素分析显示,MA是一个显著的独立因素,其次是淋巴结状态。这些发现表明,应根据所占面积评估AgNOR的表达,并且每个细胞核的AgNOR平均面积(MA)是乳腺癌患者总生存期的一个重要预后因素。